Skip to main content

Research Repository

Advanced Search

Outputs (37)

GOF Mutant p53 in Cancers: A Therapeutic Challenge (2022)
Journal Article
Lobsang, D., & Muller, P. A. (2022). GOF Mutant p53 in Cancers: A Therapeutic Challenge. Cancers, 14(20), Article 5091. https://doi.org/10.3390/cancers14205091

TP53 is mutated in the majority of human cancers. Mutations can lead to loss of p53 expression or expression of mutant versions of the p53 protein. These mutant p53 proteins have oncogenic potential. They can inhibit any remaining WTp53 in a dominant... Read More about GOF Mutant p53 in Cancers: A Therapeutic Challenge.

Rab11-FIP1/RCP functions as a major signalling hub in the oncogenic roles of mutant p53 in cancer (2021)
Journal Article
von Grabowiecki, Y., Phatak, V., Aschauer, L., & Muller, P. A. (2021). Rab11-FIP1/RCP functions as a major signalling hub in the oncogenic roles of mutant p53 in cancer. Frontiers in Oncology, 11, Article 804107. https://doi.org/10.3389/fonc.2021.804107

Rab11-FIP1 is a Rab effector protein that is involved in endosomal recycling and trafficking of various molecules throughout the endocytic compartments of the cell. The consequence of this can be increased secretion or increased membrane expression o... Read More about Rab11-FIP1/RCP functions as a major signalling hub in the oncogenic roles of mutant p53 in cancer.

Evaluation of the role of p53 tumor suppressor post-translational modifications and TTC5 cofactor in lung cancer (2021)
Journal Article
Alhebshi, H., Tian, K., Patnaik, L., Taylor, R., Bezecny, P., Hall, C., …Krstic-Demonacos, M. (2021). Evaluation of the role of p53 tumor suppressor post-translational modifications and TTC5 cofactor in lung cancer. International Journal of Molecular Sciences, 22(24), Article 13198. https://doi.org/10.3390/ijms222413198

Mutations in the p53 tumor suppressor are found in over 50% of cancers. p53 function is controlled through posttranslational modifications and cofactor interactions. In this study, we investigated the posttranslationally modified p53, including p53 a... Read More about Evaluation of the role of p53 tumor suppressor post-translational modifications and TTC5 cofactor in lung cancer.

Erratum to: Genomic instability in mutant p53 cancer cells upon entotic engulfment (Nature Communications, (2018), 9, 1, (3070), 10.1038/s41467-018-05368-1) (2018)
Journal Article
Mackay, H., Moore, D., Hall, C., Birkbak, N., Jamal-Hanjani, M., Karim, S., …Muller, P. (2018). Erratum to: Genomic instability in mutant p53 cancer cells upon entotic engulfment (Nature Communications, (2018), 9, 1, (3070), 10.1038/s41467-018-05368-1). Nature Communications, 9(1), https://doi.org/10.1038/s41467-018-06026-2

Mutant p53 regulates dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype (2013)
Journal Article
Muller, P., Trinidad, A., Caswell, P., Norman, J., & Vousden, K. (2014). Mutant p53 regulates dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype. Journal of Biological Chemistry, 289(1), 122-132. https://doi.org/10.1074/jbc.m113.502138

The control and processing of microRNAs (miRs) is critical in the regulation of all cellular responses. Previous studies have suggested that a reduction in the expression of certain miRs, or an overall decrease in miR processing through the partial d... Read More about Mutant p53 regulates dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype.